Upgrade to SI Premium - Free Trial

Needham Reiterates Buy Rating on Veracyte, Inc (VCYT)

September 15, 2026 5:22 AM
Needham analyst Mike Matson reiterated a Buy rating and $69.00 price target on Veracyte, Inc (NASDAQ: VCYT).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments